RT Journal Article
SR Electronic
T1 Estimates of regional infectivity of COVID-19 in the United Kingdom following imposition of social distancing measures
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.13.20062760
DO 10.1101/2020.04.13.20062760
A1 Robert Challen
A1 Krasimira Tsaneva-Atanasova
A1 Martin Pitt
A1 Tom Edwards
A1 Luke Gompels
A1 Lucas Lacasa
A1 Ellen Brooks-Pollock
A1 Leon Danon
YR 2020
UL http://medrxiv.org/content/early/2020/11/13/2020.04.13.20062760.abstract
AB The SARS-CoV-2 reproduction number has become an essential parameter for monitoring disease transmission across settings and guiding interventions. The UK published weekly estimates of the reproduction number in the UK starting in May 2020 which are formed from multiple independent estimates. In this paper, we describe methods used to estimate the time-varying SARS-CoV-2 reproduction number for the UK. We used multiple data sources and estimated a serial interval distribution from published studies. We describe regional variability and how estimates evolved during the early phases of the outbreak, until the relaxing of social distancing measures began to be introduced in early July. Our analysis is able to guide localised control and provides a longitudinal example of applying these methods over long timescales.Competing Interest StatementThe authors have declared no competing interest.Funding StatementRC and KTA gratefully acknowledges the financial support of the EPSRC via grant EP/N014391/1 and NHS England, Global Digital Exemplar programme. LD and KTA gratefully acknowledges the financial support of The Alan Turing Institute under the EPSRC grant EP/N510129/1. LL acknowledges the financial support of the EPSRC via Early Career Fellowship EP/P01660X/1. LD and EBP are supported by Medical Research Council (MRC) (MC/PC/19067). EBP was partly supported by the NIHR Health Protection Research Unit in Behavioural Science and Evaluation at University of Bristol, in partnership with Public Health England (PHE). Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is public domain and accessible through GitHub https://github.com/terminological/uk-covid-datatools/vignettes/current-rt